Switch to:

Denali Therapeutics Price-to-Operating-Cash-Flow

: (As of Today)
View and export this data going back to 2017. Start your Free Trial

As of today (2019-11-14), Denali Therapeutics's share price is $15.00. Denali Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.10. Hence, Denali Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

Denali Therapeutics's Cash Flow from Operations per share for the three months ended in Sep. 2019 was $-0.32. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.10.


Denali Therapeutics Price-to-Operating-Cash-Flow Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Price-to-Operating-Cash-Flow 0.00 0.00 0.00 38.19

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 38.19 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Price-to-Operating-Cash-Flow Distribution

* The bar in red indicates where Denali Therapeutics's Price-to-Operating-Cash-Flow falls into.



Denali Therapeutics Price-to-Operating-Cash-Flow Calculation

Denali Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=15.00/-0.1
=

Denali Therapeutics's Share Price of today is $15.00.
Denali Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2019 was 0.988 (Dec. 2018 ) + -0.319 (Mar. 2019 ) + -0.452 (Jun. 2019 ) + -0.317 (Sep. 2019 ) = $-0.10.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Denali Therapeutics Price-to-Operating-Cash-Flow Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)